ArticleJournal of the American Academy of Dermatology2019

The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers.

Laura Karas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.